“
“Purpose/Objectives: To explore (a) how women who were diagnosed with breast cancer (BC) defined themselves as survivors and when this occurred, and (b) the types of benefits they derived from their experiences.\n\nResearch Approach: An exploratory, qualitative approach.\n\nParticipants:

112 women who had BC (response rate = 70%).\n\nSetting: Participants were recruited from two cancer survivor organizations in a northeastern U.S. city.\n\nMethodologic Approach: Responses to open-ended questions in telephone interviews were examined by age at diagnosis using thematic analysis. Chi squares were used to conduct analyses by age (younger than 51 years; aged 51 years or older).\n\nMain Research Variables: Meaning of survivorship, defining moment, benefits derived from surviving from breast cancer.\n\nFindings: Alvespimycin datasheet Participants’ perceptions of survivorship included two main components, a defining moment and the meaning attached to being a survivor. Becoming a survivor is an active process, except in the case of those participants who realized they were survivors when informed by a third party. Meanings differed by age at diagnosis. Most participants listed at least one benefit from surviving cancer.\n\nConclusions: The

definitions of survivorship and benefits outlined here suggest that many positive aspects of the survivorship Momelotinib molecular weight experience exist that may inform future interventions’ designs.\n\nImplications for Practice: Providers should acknowledge the strength

survivors show in the process of meaning-making and finding benefits in their adverse experiences. The use of expressive and supportive interventions may hold promise for women facing difficulties buy AG-014699 in coping with their diagnosis.”
“Exclusive enteral nutrition (EEN) induces clinical and mucosal healing (MH) in Crohn’s disease (CD), with MH the best determinant of future outcome. We investigated efficacy of EEN for inducing early clinical, biochemical, mucosal and transmural remission of CD and related early endoscopic response to outcomes at 1 year. In a prospective, open label study 34 children (mean 13.1 years; 21 males) with new diagnosis CD were offered EEN, 26 completed a minimum 6 weeks EEN and underwent paired clinical, biochemical and endoscopic assessment at start and completion using PCDAI, BMI, CRP and Simple Endoscopic Score for CD (SES-CD). A subset, 16/26, had paired MR enterography scored. Early good endoscopic response (complete MH, or near complete, SES-CD 0-3) was related to outcome at 1 year. EEN improved mean PCDAI (37.88-7.01, p smaller than 0.001; BMI Z scores (-1.54 to -0.54, p smaller than 0.01); weight Z score (-0.79 to -0.08, p smaller than 0.03); CRP (44.86-5.5, p smaller than 0.001); endoscopy (SES-CD 14.28-3.88, p smaller than 0.001) and MRE (5.14-2.